Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

The First Functional HLA-a*01:01-Restricted EBV-LMP2-Specific T-Cell Receptors for TCR Gene Therapy of Patients with EBV-Associated Type II/III Malignancies

Wesley Huisman, MSc, Ilse Gille, Lieve E. van der Maarel, Lois Hageman, Rob C.M. de Jong, PhD, Derk Amsen, PhD, Fred Falkenburg, MD PhD, Inge Jedema, PhD

Blood (2019) 134 (Supplement_1): 4448.

https://doi.org/10.1182/blood-2019-123736

Published: 2019

Journal Articles

Recurrent JAK3 Mutations in Post-Transplant Lymphoproliferative Disorder

Alexandra Butzmann, MD, Diwash Jangam, PhD, Jyoti Kumar, MDMS, Kaushik Sridhar, MS, Benjamin A Pinsky, MD PhD, Robert S. Ohgami, MD PhD

Blood (2019) 134 (Supplement_1): 5226.

https://doi.org/10.1182/blood-2019-131146

Published: 2019

Journal Articles

Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset

Samuel Yamshon, MD, Miguel Dario Cantu, Ethel Cesarman, MD PhD, Sarah C. Rutherford, MD, Amy Chadburn, MD, Genevieve Marie Crane, MD PhD

Blood (2019) 134 (Supplement_1): 2792.

https://doi.org/10.1182/blood-2019-128374

Published: 2019

Journal Articles

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Thomas M. Habermann, MD, Angelo Fama, MD, Kay M. Ristow, BS, Matthew J. Maurer, MS, William R. Macon, MD, Stephen M. Ansell, MD PhD, Nabila Nora Bennani, MD, Yogish C Kudva, MBBS, Randall C. Walker, MD, Kimberly D. Watt, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 456.

https://doi.org/10.1182/blood-2018-99-113667

Published: 2018

Journal Articles

Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

Angelo Fama, MD, Rebecca L King, MD, Matthew J. Maurer, MS, Kay M. Ristow, BS, William R Macon, MD, Stephen M Ansell, MD, Nora N Bennani, MD, Randall C. Walker, MD, Yogish C Kudva, MBBS, Kymberly D Watt, MD, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD

Blood (2018) 132 (Supplement 1): 2979.

https://doi.org/10.1182/blood-2018-99-116738

Published: 2018

Journal Articles

ITP or Not-ITP - a Rare Case of PTLD Recurrence Presenting As Autoimmune Thrombocytopenia

Vikas Kumar Singh, MD, Margaret Means, Danh Pham, MD, Goetz H Kloecker, MD

Blood (2016) 128 (22): 4942.

https://doi.org/10.1182/blood.V128.22.4942.4942

Published: 2016

Journal Articles

Genomic and Targeted Mutational Analysis of T/NK-Cell Post-Transplant Lymphoproliferative Disorders Provides Insight into Disease Biology

Elizabeth Michelle Margolskee, MD, Vaidehi Jobanputra, Preti Jain, Jinli Chen, Odelia Nahum, Brynn Levy, Karthik A Ganapathi, MD PhD, Vundavalli Murty, Thomas Tousseyn, MDPhD, Bachir Alobeid, MD, Mahesh Manuskhani, MD, Govind Bhagat, MD MBBS

Blood (2015) 126 (23): 1475.

https://doi.org/10.1182/blood.V126.23.1475.1475

Published: 2015

Journal Articles

Morphologic Evolution in Post-Transplant Lymphoproliferative Disorders (PTLD): A Clinicopathologic Case Series

Ryan J. Stubbins, MD BSc, Anthea C Peters, MD M.Sc., FRCPC, Mabilang Curtis, BSc, Carolyn Owen, MD, Adnan Mansoor, MD FRCPC, Raymond Lai, MD PhD, Jutta Preiksaitis, MD FRCPC

Blood (2015) 126 (23): 5008.

https://doi.org/10.1182/blood.V126.23.5008.5008

Published: 2015

Journal Articles

Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab

Amit Kalra, MBBS, MS, Cameron Roessner, BScPharm, Jennifer Jupp, BScPharm,BCOP, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 3114.

https://doi.org/10.1182/blood.V126.23.3114.3114

Published: 2015

Journal Articles

A Rise in CNS Lymphoproliferative Disease Incidence Reveals a Protective Role of Calcineurin Inhibitors

Genevieve M. Crane, MD PhD, Helen Powell, PhD, Rumen Kostadinov, PhD, Richard F. Ambinder, MD PhD, Lode J. Swinnen, Michael Borowitz, MD PhD, Amy S. Duffield, MD PhD

Blood (2014) 124 (21): 3020.

https://doi.org/10.1182/blood.V124.21.3020.3020

Published: 2014

Journal Articles

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Britta Maecker-Kolhoff, MD, Rita Beier, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Ulrich Baumann, MD, Carsten Mueller, MD, Lars Pape, MD, Alfred Reiter, MD, Claudia Rossig, MD, Stephan Schubert, MD, Burkhard Toenshoff, MD, Anne-Margret Wingen, MD, Barbara Meissner, MD, Christian Kebelmann-Betzing, MD, Guenter Henze, MD, Hans H. Kreipe, MD, Christoph Klein, MD PhD

Blood (2014) 124 (21): 4468.

https://doi.org/10.1182/blood.V124.21.4468.4468

Published: 2014

Journal Articles

Hodgkin’s Disease / Hodgkin-PTLD after Solid Organ Transplantation in Children: A Report on 16 Patients Treated According to Subsequent Gpoh-HD Treatment Schedules

Johanna Kampers, Rita Beier, MD, Manuela A. Orjuela-Grimm, MD ScM, Tilmann Schober, MD, Thomas Schulz, MD, Martina Stiefel, MD, Christoph Klein, MD PhD, Christine Mauz-Koerholz, MD, Hans H. Kreipe, MD, Britta Maecker-Kolhoff, MD

Blood (2014) 124 (21): 1612.

https://doi.org/10.1182/blood.V124.21.1612.1612

Published: 2014

Journal Articles

Tumor Microenvironmental Features and Outcome in Post-Transplant Lymphoproliferative Disorder

Maja Ølholm Vase, MD, Eva Maksten, MDcal student, Knud Bendix, Stephen Jacques Hamilton-Dutoit, Claus Andersen, Michael B. Møller, MD DMSc, Søren Schwartz Sørensen, Bente Jespersen, MD, Jan Kampmann, Gabriel Rabinovich, PhD, Esben Søndergård, Patricia Switten Nielsen, Francesco d'Amore

Blood (2014) 124 (21): 1617.

https://doi.org/10.1182/blood.V124.21.1617.1617

Published: 2014

Journal Articles

Inactivation Of BANK1 By a Novel IGH -Associated Translocation and 5’ Hypermethylation In B-Cell Lymphomas

Kui Nie, PhD, Taotao Zhang, MD, PhD, Jiong Yan, MD, PhD, Leonardo Boiocchi, MD, Shuhua Cheng, PhD, Susan Mathew, PhD, Yifang Liu, MD, Amy Chadburn, M.D., Attilio Orazi, MD, Daniel M Knowles, MD, Yen-Chun Liu, MD, PHD, Wayne Tam, MD, PhD

Blood (2013) 122 (21): 2497.

https://doi.org/10.1182/blood.V122.21.2497.2497

Published: 2013

Journal Articles

Next-Generation High Throughput Sequencing Analysis In The Search Of Infectious Pathogens In Suspect Lymphoproliferations

Daniela Hoehn, MD, PhD, Jordan M. Schecter, MD, David Hirschberg, MD, Cadhla Firth, Craig R Street, Bachir Alobeid, MD, Ian W Lipkin, MD, Govind Bhagat, MD

Blood (2013) 122 (21): 3019.

https://doi.org/10.1182/blood.V122.21.3019.3019

Published: 2013

Journal Articles

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Jordan M. Schecter, MD, Daniela Hoehn, MD, PhD, Philip Imus, MD, Eleonora Alma, BS, Suzanne Lentzsch, MD, PhD, Bachir Alobeid, MD, Manuela Orjuela, MD, ScM, Owen A. O'Connor, MD, PhD, Govind Bhagat, MD

Blood (2013) 122 (21): 4333.

https://doi.org/10.1182/blood.V122.21.4333.4333

Published: 2013

Journal Articles

Early onset, EBV − PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis

Anamarija M. Perry, Patricia Aoun, Donald W. Coulter, Warren G. Sanger, Wendy J. Grant, Peter F. Coccia

Blood (2013) 121 (8): 1377–1383.

https://doi.org/10.1182/blood-2012-06-438549

Published: 2013

Journal Articles

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

Ludmila Katherine Martin, MD, Mark E Lustberg, MD, PhD, Fengting Yan, M.D., Ph.D., John T. Patton, Pierluigi Porcu, MD, Gerard Nuovo, M.D., Robert Cavaliere, MD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 3067.

https://doi.org/10.1182/blood.V118.21.3067.3067

Published: 2011

Journal Articles

Viral induction and targeted inhibition of galectin-1 in EBV + posttransplant lymphoproliferative disorders

Jing Ouyang, Przemyslaw Juszczynski, Scott J. Rodig, Michael R. Green, Evan O'Donnell, Treeve Currie, Myriam Armant, Kunihiko Takeyama, Stefano Monti, Gabriel A. Rabinovich, Jerome Ritz, Jeffery L. Kutok, Margaret A. Shipp

Blood (2011) 117 (16): 4315–4322.

https://doi.org/10.1182/blood-2010-11-320481

Published: 2011

Includes: Supplemental data

Journal Articles

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Jing Ouyang, PhD, Przemyslaw Juszczynski, MD, PhD, Evan O'Donnell, Myriam Armant, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Stefano Monti, PhD, Gabriel Rabinovich, PhD, Jeffery Lorne Kutok, MD, PhD, Jerome Ritz, MD, Margaret A. Shipp, MD

Blood (2009) 114 (22): 96.

https://doi.org/10.1182/blood.V114.22.96.96

Published: 2009

NARROW

The First Functional HLA-a*01:01-Restricted EBV-LMP2-Specific T-Cell Receptors for TCR Gene Therapy of Patients with EBV-Associated Type II/III Malignancies

Recurrent JAK3 Mutations in Post-Transplant Lymphoproliferative Disorder

Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

ITP or Not-ITP - a Rare Case of PTLD Recurrence Presenting As Autoimmune Thrombocytopenia

Genomic and Targeted Mutational Analysis of T/NK-Cell Post-Transplant Lymphoproliferative Disorders Provides Insight into Disease Biology

Morphologic Evolution in Post-Transplant Lymphoproliferative Disorders (PTLD): A Clinicopathologic Case Series

Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab

A Rise in CNS Lymphoproliferative Disease Incidence Reveals a Protective Role of Calcineurin Inhibitors

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Hodgkin’s Disease / Hodgkin-PTLD after Solid Organ Transplantation in Children: A Report on 16 Patients Treated According to Subsequent Gpoh-HD Treatment Schedules

Tumor Microenvironmental Features and Outcome in Post-Transplant Lymphoproliferative Disorder

Inactivation Of BANK1 By a Novel IGH -Associated Translocation and 5’ Hypermethylation In B-Cell Lymphomas

Next-Generation High Throughput Sequencing Analysis In The Search Of Infectious Pathogens In Suspect Lymphoproliferations

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Early onset, EBV − PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

Viral induction and targeted inhibition of galectin-1 in EBV + posttransplant lymphoproliferative disorders

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only